A bibliometric analysis of CD38-targeting antibody therapy in multiple myeloma from 1985 to 2021.

Translational cancer research(2022)

引用 3|浏览3
暂无评分
摘要
In the past, efforts were applied to elucidate the mechanism and effectiveness of CD38-targeting antibodies in treating MM. Future research hotspots will focus on anti-BCMA chimeric antigen receptor T cell (CAR-T) immunotherapy for patients with RRMM. According to this article, new researchers can discover its course of development and structural relationships in this field.
更多
查看译文
关键词
CD38-targeting antibody,CiteSpace,Multiple myeloma,VOSviewer,bibliometric analysis,daratumumab,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要